Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 107

1.

Natalizumab during pregnancy and lactation.

Proschmann U, Thomas K, Thiel S, Hellwig K, Ziemssen T.

Mult Scler. 2017 Aug 1:1352458517728813. doi: 10.1177/1352458517728813. [Epub ahead of print]

PMID:
28857686
2.

Breastfeeding, ovulatory years, and risk of multiple sclerosis.

Langer-Gould A, Smith JB, Hellwig K, Gonzales E, Haraszti S, Koebnick C, Xiang A.

Neurology. 2017 Aug 8;89(6):563-569. doi: 10.1212/WNL.0000000000004207. Epub 2017 Jul 12.

PMID:
28701499
3.

Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response.

Stellmann JP, Krumbholz M, Friede T, Gahlen A, Borisow N, Fischer K, Hellwig K, Pache F, Ruprecht K, Havla J, Kümpfel T, Aktas O, Hartung HP, Ringelstein M, Geis C, Kleinschnitz C, Berthele A, Hemmer B, Angstwurm K, Young KL, Schuster S, Stangel M, Lauda F, Tumani H, Mayer C, Zeltner L, Ziemann U, Linker RA, Schwab M, Marziniak M, Then Bergh F, Hofstadt-van Oy U, Neuhaus O, Zettl U, Faiss J, Wildemann B, Paul F, Jarius S, Trebst C, Kleiter I; NEMOS (Neuromyelitis Optica Study Group).

J Neurol Neurosurg Psychiatry. 2017 Aug;88(8):639-647. doi: 10.1136/jnnp-2017-315603. Epub 2017 Jun 1.

4.

Treatment of multiple sclerosis during pregnancy - safety considerations.

Thöne J, Thiel S, Gold R, Hellwig K.

Expert Opin Drug Saf. 2017 May;16(5):523-534. doi: 10.1080/14740338.2017.1311321. Epub 2017 Apr 17. Review.

PMID:
28333552
5.

Successful pregnancy after natalizumab-associated progressive multifocal leukoencephalopathy in a patient with multiple sclerosis.

Pitarokoili K, Hellwig K, Lukas C, Gold R.

Mult Scler. 2017 Mar;23(3):483-486. doi: 10.1177/1352458516678475. Epub 2016 Nov 12.

PMID:
28260421
6.

[Minor Victims of Violent Acts in the Context of the Victim Reparation Law].

Hellwig K, Kröger C, Franke S, Wehrmeyer M, Heinrichs N.

Z Kinder Jugendpsychiatr Psychother. 2017 Feb 6:1-10. doi: 10.1024/1422-4917/a000508. [Epub ahead of print] German.

PMID:
28165300
7.

Influence of female sex and fertile age on neuromyelitis optica spectrum disorders.

Borisow N, Kleiter I, Gahlen A, Fischer K, Wernecke KD, Pache F, Ruprecht K, Havla J, Krumbholz M, Kümpfel T, Aktas O, Ringelstein M, Geis C, Kleinschnitz C, Berthele A, Hemmer B, Angstwurm K, Weissert R, Stellmann JP, Schuster S, Stangel M, Lauda F, Tumani H, Mayer C, Zeltner L, Ziemann U, Linker RA, Schwab M, Marziniak M, Then Bergh F, Hofstadt-van Oy U, Neuhaus O, Winkelmann A, Marouf W, Rückriem L, Faiss J, Wildemann B, Paul F, Jarius S, Trebst C, Hellwig K; NEMOS (Neuromyelitis Optica Study Group).

Mult Scler. 2017 Jul;23(8):1092-1103. doi: 10.1177/1352458516671203. Epub 2016 Oct 6.

PMID:
27758954
8.

Synthesis, Electrochemical Characterization, and Linear Free Energy Relationship of 1,3-Diphenyl-6-alkyl/arylfulvenes.

Godman NP, Adas SK, Hellwig KM, Ball DW, Balaich GJ, Iacono ST.

J Org Chem. 2016 Oct 21;81(20):9630-9638. Epub 2016 Oct 12.

PMID:
27689910
9.

Predictors of severity and functional outcome in natalizumab-associated progressive multifocal leukoencephalopathy.

Hoepner R, Kolb EM, Dahlhaus S, Hellwig K, Adams O, Kleiter I, Salmen A, Schneider R, Lukas C, Chan A, Berger JR, Gold R.

Mult Scler. 2017 May;23(6):830-835. doi: 10.1177/1352458516667241. Epub 2016 Sep 6.

PMID:
27600113
10.

Plasmapheresis and immunoadsorption in patients with steroid refractory multiple sclerosis relapses.

Faissner S, Nikolayczik J, Chan A, Hellwig K, Gold R, Yoon MS, Haghikia A.

J Neurol. 2016 Jun;263(6):1092-8. doi: 10.1007/s00415-016-8105-4. Epub 2016 Apr 2.

PMID:
27039388
11.

Oral Contraceptives and Multiple Sclerosis/Clinically Isolated Syndrome Susceptibility.

Hellwig K, Chen LH, Stancyzk FZ, Langer-Gould AM.

PLoS One. 2016 Mar 7;11(3):e0149094. doi: 10.1371/journal.pone.0149094. eCollection 2016.

12.

Relevance of endoglin, IL-1α, IL-1β and anti-ovarian antibodies in females with multiple sclerosis.

Thöne J, Kleiter I, Stahl A, Ellrichmann G, Gold R, Hellwig K.

J Neurol Sci. 2016 Mar 15;362:240-3. doi: 10.1016/j.jns.2016.01.057. Epub 2016 Jan 28.

PMID:
26944156
13.

[Monitoring of blood parameters under course-modified MS therapy : Substance-specific relevance and current recommendations for action].

Klotz L, Berthele A, Brück W, Chan A, Flachenecker P, Gold R, Haghikia A, Hellwig K, Hemmer B, Hohlfeld R, Korn T, Kümpfel T, Lang M, Limmroth V, Linker RA, Meier U, Meuth SG, Paul F, Salmen A, Stangel M, Tackenberg B, Tumani H, Warnke C, Weber MS, Ziemssen T, Zipp F, Wiendl H.

Nervenarzt. 2016 Jun;87(6):645-59. doi: 10.1007/s00115-016-0077-1. Review. German.

PMID:
26927677
14.

Breastfeeding and Disease-Modifying Therapy for Multiple Sclerosis--Reply.

Hellwig K, Langer-Gould AM.

JAMA Neurol. 2016 Apr;73(4):480-1. doi: 10.1001/jamaneurol.2015.4821. No abstract available.

PMID:
26926044
15.

Interferon-beta exposure during first trimester is safe in women with multiple sclerosis-A prospective cohort study from the German Multiple Sclerosis and Pregnancy Registry.

Thiel S, Langer-Gould A, Rockhoff M, Haghikia A, Queisser-Wahrendorf A, Gold R, Hellwig K.

Mult Scler. 2016 May;22(6):801-9. doi: 10.1177/1352458516634872. Epub 2016 Feb 26.

PMID:
26920382
16.

Efficacy of glatiramer acetate in neuromyelitis optica spectrum disorder: a multicenter retrospective study.

Ayzenberg I, Schöllhammer J, Hoepner R, Hellwig K, Ringelstein M, Aktas O, Kümpfel T, Krumbholz M, Trebst C, Paul F, Pache F, Obermann M, Zeltner L, Schwab M, Berthele A, Jarius S, Kleiter I; Neuromyelitis Optica Study Group.

J Neurol. 2016 Mar;263(3):575-82. doi: 10.1007/s00415-015-7991-1. Epub 2016 Jan 25.

PMID:
26810718
17.

Glatiramer acetate during early pregnancy: A prospective cohort study.

Herbstritt S, Langer-Gould A, Rockhoff M, Haghikia A, Queisser-Wahrendorf A, Gold R, Hellwig K.

Mult Scler. 2016 May;22(6):810-6. doi: 10.1177/1352458515623366. Epub 2016 Jan 11.

PMID:
26754804
18.

Multiple sclerosis in men: management considerations.

Bove R, McHenry A, Hellwig K, Houtchens M, Razaz N, Smyth P, Tremlett H, Sadovnick AD, Rintell D.

J Neurol. 2016 Jul;263(7):1263-73. doi: 10.1007/s00415-015-8005-z. Epub 2016 Jan 2. Review.

PMID:
26725085
19.

Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer's disease.

Hellwig K, Kvartsberg H, Portelius E, Andreasson U, Oberstein TJ, Lewczuk P, Blennow K, Kornhuber J, Maler JM, Zetterberg H, Spitzer P.

Alzheimers Res Ther. 2015 Dec 24;7:74. doi: 10.1186/s13195-015-0161-y.

20.

Multiple sclerosis and family planning.

Hellwig K.

Neurodegener Dis Manag. 2015;5(6 Suppl):39-42. doi: 10.2217/nmt.15.61. Review. No abstract available.

PMID:
26611271

Supplemental Content

Loading ...
Support Center